Changes in purchasing patterns after glucagon-like peptide-1 receptor agonist (GLP-1RA) initiation were seen across most nutrient ...
Biomed Industries, Inc. Announces Two NA-931 Phase 3 Trials, Targeting Durable Weight Loss & Lean-Mass Preservation ...
Flow Space on MSN
Is this the secret to maintaining a healthy weight in menopause?
The GLP-1 tirzepatide is only one half of the puzzle.
Researchers conducted a cohort study to assess the effect of incretin receptor agonist therapy on continuous positive airway pressure use in T2D, obesity, and OSA.
Assistant Controller of Patents (C.A. (COMM.IPD-PAT) 76/2022), the Delhi High Court upheld the refusal of a patent ...
News Medical on MSN
New trial tests strategies to protect heart health during prostate cancer therapy
City of Hope ® , one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation's top cancer centers by ...
This randomized controlled trial shows that structured moderate-to-vigorous exercise, alone or combined with liraglutide, ...
The phase 3b TOGETHER-PsA trial evaluated the safety and efficacy of concomitant ixekizumab and tirzepatide in adults with active psoriatic arthritis and obesity.
Sun Pharma has received approval from the Drugs Controller General of India to manufacture and market a generic version of semaglutide injection. Semaglutide, a glucagon-like peptide-1 receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results